Parametric Portfolio Associates’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $269K | Sell |
17,629
-857
| -5% | -$13.1K | ﹤0.01% | 3327 |
|
|
2021
Q4 | $327K | Sell |
18,486
-13,255
| -42% | -$234K | ﹤0.01% | 3249 |
|
|
2021
Q3 | $667K | Buy |
31,741
+2,429
| +8% | +$51K | ﹤0.01% | 2973 |
|
|
2021
Q2 | $578K | Sell |
29,312
-18,330
| -38% | -$361K | ﹤0.01% | 3016 |
|
|
2021
Q1 | $1.39M | Buy |
47,642
+12,156
| +34% | +$353K | ﹤0.01% | 2993 |
|
|
2020
Q4 | $1.08M | Sell |
35,486
-1,545
| -4% | -$46.8K | ﹤0.01% | 3015 |
|
|
2020
Q3 | $589K | Sell |
37,031
-317
| -0.8% | -$5.04K | ﹤0.01% | 3193 |
|
|
2020
Q2 | $737K | Sell |
37,348
-805
| -2% | -$15.9K | ﹤0.01% | 3083 |
|
|
2020
Q1 | $470K | Buy |
38,153
+22,213
| +139% | +$274K | ﹤0.01% | 3191 |
|
|
2019
Q4 | $295K | Sell |
15,940
-3,388
| -18% | -$62.7K | ﹤0.01% | 3575 |
|
|
2019
Q3 | $268K | Buy |
+19,328
| New | +$268K | ﹤0.01% | 3597 |
|